Iovance Biotherapeutics
+$1.21 (+8.75%) Today
-$0.44 (-2.93%) As of 1:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IOVA and other ETFs, options, and stocks.
About IOVA
Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors.
CEO
Frederick G. Vogt
Employees
241
Headquarters
San Carlos, California
Founded
2007
IOVA Key Statistics
Market cap
2.36B
Price-Earnings ratio
—
Dividend yield
—
Average volume
2.48M
High today
$15.04
Low today
$13.90
Open price
$14.36
Volume
2.29M
52 Week high
$53.04
52 Week low
$13.28
Analyst ratings
77%
of 13 ratings
Buy
76.9%
Hold
23.1%
Sell
0%
IOVA Earnings
-$0.55
-$0.37
-$0.18
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Feb 24, After Hours